Finance
Victoria’s Secret appears to be trading at ‘negative value’, RBC says
In the first half of this year, Victoria’s Secret sales rose 4% but earnings before some items fell 50%. By Tunick’s estimation, the company’s core brand is losing more than $800 million in profits.
At the same time, Tunick expects that Bath & Body Works, an L Brands-owned franchise which provides products for personal care, will contribute over 70% of the company’s bottom line this year, compared with 40% a few years ago.
This is a showcase of “BBW’s strength and VS’s profit challenges,” Tunick said Monday in a note sent out to clients.
“While BBW continues to shine, the VS turnaround is taking longer along with rising Pink concerns,” Tunick said. “At current levels, the market appears to be assigning little to negative value to the $7B VS franchise, which we believe could re-rate once investors see some signs of stabilization.”
Tunick cut his price target for L Brands from $40 to $35 — slightly above where the shares were trading early on Tuesday — but maintained his “outperform” rating.
Randal Konik, an analyst at Jefferies, also recently published his concerns about L Brands. In a note to clients on Monday, he said the company was weakening its brand image through discounts, and this served as a red flag.
Pink, another business owned by L Brands, now offers deeper promotions than Victoria’s Secret. This makes L Brand’s business “scary,” said Konik, who has a $23 price target and maintains an “underperform” rating on the retailer.
-
Business7 days ago
This camera trades pictures for AI poetry
-
Business6 days ago
TikTok Shop expands its secondhand luxury fashion offering to the UK
-
Business7 days ago
Boston Dynamics unveils a new robot, controversy over MKBHD, and layoffs at Tesla
-
Business5 days ago
Mood.camera is an iOS app that feels like using a retro analog camera
-
Business5 days ago
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
-
Business4 days ago
Tesla’s new growth plan is centered around mysterious cheaper models
-
Business3 days ago
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
-
Entertainment5 days ago
Furious Watcher fans are blasting it as ‘greedy’ over paid subscription service